A novel model to study COVID-19 and Hypertension
A novel model to study COVID-19 and Hypertension
批准号:
10428648
负责人:
BINA JOE
金额:
$19.31万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-14 至 2023-05-31
关键词:
2019-nCoVACE2AddressAnimal ModelAnimalsAntihypertensive AgentsBlood PressureCOVID-19COVID-19 pandemicCOVID-19 pathogenesisCOVID-19 severityCOVID-19 therapeuticsCOVID-19 vaccineCOVID-19 vaccine evaluationCRISPR/Cas technologyCommunitiesContractsDahl Hypertensive RatsDataDevelopmentDietDietary SodiumEtiologyExperimental ModelsFelis catusFerretsGene ExpressionGenesGerm-FreeHamstersHandHumanHypertensionIndividualIntakeK-18 conjugateKnock-inKnock-outKnowledgeLightMedicalModelingMusNamesOrganPathogenesisPathologyPatientsPlayPredispositionPublishingRattusReportingResearchRiskRoleSARS-CoV-2 infectionSARS-CoV-2 transmissionSodium ChlorideSodium-Restricted DietStudy modelsSymbiosisTestingTherapeuticTimeTransgenic MiceVirusVirus SheddingWorkanimal databasedesigndietary saltdysbiosiseffectiveness evaluationfecal transplantationgut microbiotahigh riskhigh salt diethost microbiotahypertensivehypertensivesin vivointerestmicrobialmicrobiotanonhuman primatenovelnovel coronavirusprotein expressionreceptorsalt sensitivesalt sensitive hypertensionsexvaccine development
中文摘要
7.项目总结/摘要
动物模型对于理解COVID-19的病理学以及开发
疫苗。它们对于在特定风险群体中识别COVID-19的病因也很重要,例如
有高血压病史的人。虽然有仓鼠,雪貂,猫,非人类灵长类动物和K18-
hACE 2转基因小鼠作为研究COVID-19的可能模型,没有一个能达到研究COVID-19的目的。
高血压与COVID-19易感性之间的关系,因为(1)野生型研究模型
感染了人类SARS-CoV-2和/或(2)他们在遗传上不容易患高血压。填补这一
为了满足未满足的需求,我们建议开发体内实验平台,用于在以下环境中研究COVID-19:
高血压在初步的数据中,我们提出了一种新的敲入大鼠模型的发展证据,
使用CRISPR/Cas9技术编辑的高血压Dahl盐敏感(S)大鼠,以表达人ACE 2
基因(hACE 2),其是SARS-CoV-2的受体。插入基因hACE 2以替换大鼠Ace 2基因座。
还产生了作为对照品系(rAce 2-KO)的所需大鼠Ace 2敲除。通过比较这些
2株,在目标1中,我们将检查该大鼠模型用于研究COVID-19的适用性。此外,根据我们的
最近发表的使用无菌大鼠的工作表明,将微生物群引入无菌大鼠
结肠Ace 2表达上调和血压升高结合现有的知识,
盐敏感性高血压与肠道微生物群之间的关系;在目标2中,我们将检验以下假设:
在高血压状态期间,宿主和肠道微生物群之间正常共生关系的丧失是导致
ACE 2在多个器官中表达降低。
英文摘要
7. Project Summary/Abstract
Animal models fare indispensable for understanding the pathology of COVID-19 as well as for developing
vaccines. They are also important to discern the etiology of COVID-19 in specific groups at risk, such as
individuals with pre-existing hypertension. While there are hamsters, ferrets, cats, nonhuman primates and K18-
hACE2 transgenic mice as possible models for studying COVID-19, none serves the purpose of studying the
relationship between hypertension and susceptibility to COVID-19 because (1) wild-type research models do not
get infected with the human SARS-CoV-2 and/or (2) they are not genetically prone to hypertension. To fill this
unmet need, we propose to develop in vivo experimental platform for studying COVID-19 in the setting of
hypertension. In preliminary data, we present evidence for the development of a novel knock-in rat model of the
hypertensive Dahl Salt-sensitive (S) rat edited using the CRISPR/Cas9 technology to express the human ACE2
gene (hACE2), which is the receptor for SARS-CoV-2. The gene hACE2 is inserted to replace the rat Ace2 locus.
The required rat Ace2 knockout as the control strain (rAce2-KO) has also been generated. By comparing these
2 strains, in Aim 1 we will examine the suitability of this rat model for studying COVID-19. Further, based on our
recent published work using germ-free rats indicating that introduction of microbiota to germ-free rats
upregulated colonic Ace2 expression and blood pressure combined with the existing knowledge of a strong
relationship between salt-sensitive hypertension and the gut microbiota; in Aim 2, we will test the hypothesis that
the loss of normal symbiosis between the host and gut microbiota during a hypertensive state is responsible for
the lower ACE2 expression in multiple organs.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Gut microbiota of wild fish as reporters of compromised aquatic environments sleuthed through machine learning.
通过机器学习来侦查野生鱼类的肠道微生物群,作为受损水生环境的报告者。
DOI:
10.1152/physiolgenomics.00002.2022
发表时间:
2022
期刊:
Physiological genomics
影响因子:
4.6
作者:
[TurnerJr,JohnW, Cheng,Xi, Saferin,Nilanjana, Yeo,Ji-Youn, Yang,Tao, Joe,Bina]
通讯作者:
Joe,Bina
A novel model to study COVID-19 and Hypertension
-
批准号:10287008
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2021
-
负责人:BINA JOE
-
依托单位:
Genetic, Epigenetic and Dietary Salt effects on Microbiota and Hypertension
-
批准号:9921475
-
项目类别:
-
资助金额:$66.65万
-
财政年份:2018
-
负责人:BINA JOE
-
依托单位:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
-
批准号:8390476
-
项目类别:
-
资助金额:$65.88万
-
财政年份:2011
-
负责人:BINA JOE
-
依托单位:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
-
批准号:8589002
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2011
-
负责人:BINA JOE
-
依托单位:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
-
批准号:8775253
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2011
-
负责人:BINA JOE
-
依托单位:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
-
批准号:8259243
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2011
-
负责人:BINA JOE
-
依托单位:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
-
批准号:8968260
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2011
-
负责人:BINA JOE
-
依托单位:
Genetics of Hypertension
-
批准号:7906824
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2008
-
负责人:BINA JOE
-
依托单位:
Genetics of Hypertension
-
批准号:7666125
-
项目类别:
-
资助金额:$46.84万
-
财政年份:2008
-
负责人:BINA JOE
-
依托单位:
Genetics of Hypertension
-
批准号:7526652
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2008
-
负责人:BINA JOE
-
依托单位:
Functional genomic dissection of rat blood pressure QTL
-
批准号:7064872
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2004
-
负责人:BINA JOE
-
依托单位:
Functional genomic dissection of rat blood pressure QTL
-
批准号:6914975
-
项目类别:
-
资助金额:$38.02万
-
财政年份:2004
-
负责人:BINA JOE
-
依托单位:
Functional genomic dissection of rat blood pressure QTL
-
批准号:7233998
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2004
-
负责人:BINA JOE
-
依托单位:
Functional genomic dissection of rat blood pressure QTL
-
批准号:6824447
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2004
-
负责人:BINA JOE
-
依托单位:
Genetics of Hypertension
-
批准号:9059153
-
项目类别:
-
资助金额:$58.21万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
Genetics of Hypertension
-
批准号:8728303
-
项目类别:
-
资助金额:$57.04万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
Genetic Elements Controlling Blood Pressure
-
批准号:7581659
-
项目类别:
-
资助金额:$61.55万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
Genetic Elements Controlling Blood Pressure
-
批准号:8058781
-
项目类别:
-
资助金额:$55.76万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
Genetic Elements Controlling Blood Pressure
-
批准号:8245047
-
项目类别:
-
资助金额:$55.56万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
Biochemistry and Genetics of Hypertension
-
批准号:7001191
-
项目类别:
-
资助金额:$61.98万
-
财政年份:1988
-
负责人:BINA JOE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: